Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01
Published June 20, 2018 · Recall initiated: June 7, 2018
Summary
FDA records drug Class III recall D-0877-2018, published June 20, 2018 and initiated June 7, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 1,620 bottles; Lot: Lot #: 3087136, Exp 5/20. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Product was distributed throughout the United States
- Lot
- Lot #: 3087136, Exp 5/20
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACandesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDCOctober 28, 2020
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDASotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WVMarch 25, 2020
- FDANizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.January 29, 2020
- FDAAllergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for SaleJune 20, 2018
- FDAMeijer DILL PICKLE FLAVORED CLASSIC CRUNCH POTATO CHIPS***UPC 719283594365***LOT CODE***June 20, 2018
Questions about this recall
Was Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01 recalled?
Yes. FDA published recall D-0877-2018 on June 20, 2018. Reported hazard: Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
What should I do if I have this product?
Voluntary: Firm initiated · Letter